Works by Matsuura, Kentaro

Results: 88
    1
    2
    3

    Poor Tolerability of Lenvatinib in Elderly Patients with Advanced Hepatocellular Carcinoma after Disease Progression following First-Line Atezolizumab Plus Bevacizumab: A Multicenter Study.

    Published in:
    Oncology, 2025, v. 103, n. 4, p. 311, doi. 10.1159/000541455
    By:
    • Kato, Daisuke;
    • Suzuki, Takanori;
    • Matsuura, Kentaro;
    • Okayama, Kohei;
    • Okumura, Fumihiro;
    • Nagura, Yoshihito;
    • Sobue, Satoshi;
    • Hayashi, Katsumi;
    • Kusakabe, Atsunori;
    • Hasegawa, Izumi;
    • Matoya, Sho;
    • Mizoshita, Tsutomu;
    • Kimura, Yoshihide;
    • Kondo, Hiromu;
    • Ozasa, Atsushi;
    • Kawamura, Hayato;
    • Fujiwara, Kei;
    • Nojiri, Shunsuke;
    • Kataoka, Hiromi
    Publication type:
    Article
    4

    Prognostic Nutritional Index after Introduction of Atezolizumab with Bevacizumab Predicts Prognosis in Advanced Hepatocellular Carcinoma: A Multicenter Study.

    Published in:
    Oncology, 2024, v. 102, n. 8, p. 676, doi. 10.1159/000536367
    By:
    • Suzuki, Takanori;
    • Matsuura, Kentaro;
    • Suzuki, Yuta;
    • Okumura, Fumihiro;
    • Nagura, Yoshihito;
    • Sobue, Satoshi;
    • Kato, Daisuke;
    • Kusakabe, Atsunori;
    • Koguchi, Hiroki;
    • Hasegawa, Izumi;
    • Matoya, Sho;
    • Miyaki, Tomokatsu;
    • Kimura, Yoshihide;
    • Tanaka, Yoshito;
    • Kondo, Hiromu;
    • Ozasa, Atsushi;
    • Kawamura, Hayato;
    • Kuno, Kayoko;
    • Fujiwara, Kei;
    • Nojiri, Shunsuke
    Publication type:
    Article
    5
    6

    Association Between Laboratory Values and Covert Hepatic Encephalopathy in Patients with Liver Cirrhosis: A Multicenter, Retrospective Study.

    Published in:
    Journal of Clinical Medicine, 2025, v. 14, n. 6, p. 1858, doi. 10.3390/jcm14061858
    By:
    • Koyano, Kaori;
    • Atsukawa, Masanori;
    • Tsubota, Akihito;
    • Kondo, Chisa;
    • Miwa, Takao;
    • Namisaki, Tadashi;
    • Hiraoka, Atsushi;
    • Toyoda, Hidenori;
    • Tada, Toshifumi;
    • Kobayashi, Yuji;
    • Kawata, Kazuhito;
    • Matsuura, Kentaro;
    • Mikami, Shigeru;
    • Kawabe, Naoto;
    • Oikawa, Tsunekazu;
    • Suzuki, Kenta;
    • Kawano, Tadamichi;
    • Okubo, Tomomi;
    • Arai, Taeang;
    • Tani, Joji
    Publication type:
    Article
    7

    Beneficial effect of oral semaglutide for type 2 diabetes mellitus in patients with metabolic dysfunction‐associated steatotic liver disease: A prospective, multicentre, observational study.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 4958, doi. 10.1111/dom.15898
    By:
    • Arai, Taeang;
    • Atsukawa, Masanori;
    • Tsubota, Akihito;
    • Oikawa, Tsunekazu;
    • Tada, Toshifumi;
    • Matsuura, Kentaro;
    • Ishikawa, Toru;
    • Abe, Hiroshi;
    • Kato, Keizo;
    • Morishita, Asahiro;
    • Tani, Joji;
    • Okubo, Tomomi;
    • Nagao, Mototsugu;
    • Iwabu, Masato;
    • Iwakiri, Katsuhiko
    Publication type:
    Article
    8
    9

    Serum miR-192-5p levels predict the efficacy of pegylated interferon therapy for chronic hepatitis B.

    Published in:
    PLoS ONE, 2022, v. 17, n. 2, p. 1, doi. 10.1371/journal.pone.0263844
    By:
    • Nagura, Yoshihito;
    • Matsuura, Kentaro;
    • Iio, Etsuko;
    • Fujita, Koji;
    • Inoue, Takako;
    • Matsumoto, Akihiro;
    • Tanaka, Eiji;
    • Nishiguchi, Shuhei;
    • Kang, Jong-Hon;
    • Matsui, Takeshi;
    • Enomoto, Masaru;
    • Ikeda, Hiroki;
    • Watanabe, Tsunamasa;
    • Okuse, Chiaki;
    • Tsuge, Masataka;
    • Atsukawa, Masanori;
    • Tateyama, Masakuni;
    • Kataoka, Hiromi;
    • Tanaka, Yasuhito
    Publication type:
    Article
    10

    Trends in Healthcare Access in Japan during the First Wave of the COVID-19 Pandemic, up to June 2020.

    Published in:
    International Journal of Environmental Research & Public Health, 2021, v. 18, n. 6, p. 3271, doi. 10.3390/ijerph18063271
    By:
    • Makiyama, Koji;
    • Kawashima, Takayuki;
    • Nomura, Shuhei;
    • Eguchi, Akifumi;
    • Yoneoka, Daisuke;
    • Tanoue, Yuta;
    • Kawamura, Yumi;
    • Sakamoto, Haruka;
    • Gilmour, Stuart;
    • Shi, Shoi;
    • Matsuura, Kentaro;
    • Uryu, Shinya;
    • Hashizume, Masahiro;
    • Russo, Vincenzo;
    • Mennini, Francesco Saverio;
    • Coppeta, Luca
    Publication type:
    Article
    11
    12

    Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C.

    Published in:
    Nature Genetics, 2009, v. 41, n. 10, p. 1105, doi. 10.1038/ng.449
    By:
    • Tanaka, Yasuhito;
    • Nishida, Nao;
    • Sugiyama, Masaya;
    • Kurosaki, Masayuki;
    • Matsuura, Kentaro;
    • Sakamoto, Naoya;
    • Nakagawa, Mina;
    • Korenaga, Masaaki;
    • Hino, Keisuke;
    • Hige, Shuhei;
    • Ito, Yoshito;
    • Mita, Eiji;
    • Tanaka, Eiji;
    • Mochida, Satoshi;
    • Murawaki, Yoshikazu;
    • Honda, Masao;
    • Sakai, Akito;
    • Hiasa, Yoichi;
    • Nishiguchi, Shuhei;
    • Koike, Asako
    Publication type:
    Article
    13
    14

    Development of new IL28B genotyping method using Invader Plus assay.

    Published in:
    Microbiology & Immunology, 2012, v. 56, n. 5, p. 318, doi. 10.1111/j.1348-0421.2012.00439.x
    By:
    • Kani, Satomi;
    • Tanaka, Yasuhito;
    • Matsuura, Kentaro;
    • Watanabe, Tsunamasa;
    • Yatsuhashi, Hiroshi;
    • Orito, Etsuro;
    • Inose, Ken;
    • Motojuku, Nao;
    • Wakimoto, Yukio;
    • Mizokami, Masashi
    Publication type:
    Article
    15

    Prediction of cccDNA dynamics in hepatitis B patients by a combination of serum surrogate markers.

    Published in:
    PLoS Computational Biology, 2025, v. 21, n. 1, p. 1, doi. 10.1371/journal.pcbi.1012615
    By:
    • Kim, Kwang Su;
    • Iwamoto, Masashi;
    • Kitagawa, Kosaku;
    • Park, Hyeongki;
    • Hayashi, Sanae;
    • Tsukuda, Senko;
    • Matsui, Takeshi;
    • Atsukawa, Masanori;
    • Matsuura, Kentaro;
    • Chuaypen, Natthaya;
    • Tangkijvanich, Pisit;
    • Allweiss, Lena;
    • Nishiyama, Takara;
    • Nakamura, Naotoshi;
    • Fujita, Yasuhisa;
    • Kawakami, Eiryo;
    • Nakaoka, Shinji;
    • Muramatsu, Masamichi;
    • Aihara, Kazuyuki;
    • Wakita, Takaji
    Publication type:
    Article
    16
    17

    Genome-Wide Association Study Identifies ZNF354C Variants Associated with Depression from Interferon-Based Therapy for Chronic Hepatitis C.

    Published in:
    PLoS ONE, 2016, v. 11, n. 10, p. 1, doi. 10.1371/journal.pone.0164418
    By:
    • Matsunami, Kayoko;
    • Nishida, Nao;
    • Kaneko, Naoko;
    • Ikeo, Kazuho;
    • Toyo-oka, Licht;
    • Takeuchi, Hiroshi;
    • Matsuura, Kentaro;
    • Tamori, Akihiro;
    • Nomura, Hideyuki;
    • Yoshiji, Hitoshi;
    • Imamura, Masatoshi;
    • Masaki, Naohiko;
    • Hayakawa, Tatsuro;
    • Ide, Tatsuya;
    • Shimada, Noritomo;
    • Ikeda, Fusao;
    • Hino, Keisuke;
    • Nishiguchi, Shuhei;
    • Okuse, Chiaki;
    • Nojiri, Shunsuke
    Publication type:
    Article
    18
    19
    20
    21

    Serum interleukin‐6 levels at the start of the second course of atezolizumab plus bevacizumab therapy predict therapeutic efficacy in patients with advanced hepatocellular carcinoma: a multicenter analysis.

    Published in:
    Journal of Gastroenterology & Hepatology, 2024, v. 39, n. 10, p. 2158, doi. 10.1111/jgh.16672
    By:
    • Suzuki, Takanori;
    • Matsuura, Kentaro;
    • Suzuki, Yuta;
    • Okumura, Fumihiro;
    • Nagura, Yoshihito;
    • Sobue, Satoshi;
    • Matoya, Sho;
    • Miyaki, Tomokatsu;
    • Kimura, Yoshihide;
    • Kusakabe, Atsunori;
    • Narahara, Satoshi;
    • Tokunaga, Takayuki;
    • Nagaoka, Katsuya;
    • Murakami, Shuko;
    • Inoue, Takako;
    • Kuroyanagi, Keita;
    • Kawamura, Hayato;
    • Fujiwara, Kei;
    • Nojiri, Shunsuke;
    • Kataoka, Hiromi
    Publication type:
    Article
    22

    Comparison of six hepatocellular carcinoma prediction models in Japanese patients after sustained virologic response undergoing rigorous surveillance for hepatocellular carcinoma.

    Published in:
    Journal of Gastroenterology & Hepatology, 2024, v. 39, n. 5, p. 949, doi. 10.1111/jgh.16494
    By:
    • Toyoda, Hidenori;
    • Tada, Toshifumi;
    • Uojima, Haruki;
    • Nozaki, Akito;
    • Chuma, Makoto;
    • Takaguchi, Koichi;
    • Hiraoka, Atsushi;
    • Abe, Hiroshi;
    • Itobayashi, Ei;
    • Matsuura, Kentaro;
    • Atsukawa, Masanori;
    • Watanabe, Tsunamasa;
    • Shimada, Noritomo;
    • Nakamuta, Makoto;
    • Kojima, Motoyuki;
    • Tsuji, Kunihiko;
    • Mikami, Shigeru;
    • Ishikawa, Toru;
    • Yasuda, Satoshi;
    • Tsutsui, Akemi
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29

    International multicenter validation of GES score for HCC risk stratification in chronic hepatitis C patients.

    Published in:
    Journal of Viral Hepatitis, 2022, v. 29, n. 9, p. 807, doi. 10.1111/jvh.13717
    By:
    • Shiha, Gamal;
    • Soliman, Reham;
    • Mikhail, Nabiel N. H.;
    • Carrat, Fabrice;
    • Azzi, Jessica;
    • Nathalie, Ganne‐Carrié;
    • Toyoda, Hidenori;
    • Uojima, Haruki;
    • Nozaki, Akito;
    • Takaguchi, Koichi;
    • Hiraoka, Atsushi;
    • Atsukawa, Masanori;
    • Abe, Hiroshi;
    • Matsuura, Kentaro;
    • Mikami, Shigeru;
    • Watanabe, Tsunamasa;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Suri, Vithika;
    • Osinusi, Anu
    Publication type:
    Article
    30

    Serum CXCL10 levels at the start of the second course of atezolizumab plus bevacizumab therapy predict therapeutic efficacy in patients with advanced BCLC stage C hepatocellular carcinoma: A multicenter analysis.

    Published in:
    Cancer Medicine, 2024, v. 13, n. 1, p. 1, doi. 10.1002/cam4.6876
    By:
    • Takanori Suzuki;
    • Kentaro Matsuura;
    • Yuta Suzuki;
    • Fumihiro Okumura;
    • Yoshihito Nagura;
    • Satoshi Sobue;
    • Sho Matoya;
    • Tomokatsu Miyaki;
    • Yoshihide Kimura;
    • Atsunori Kusakabe;
    • Satoshi Narahara;
    • Takayuki Tokunaga;
    • Katsuya Nagaoka;
    • Keita Kuroyanagi;
    • Hayato Kawamura;
    • Kayoko Kuno;
    • Kei Fujiwara;
    • Shunsuke Nojiri;
    • Hiromi Kataoka;
    • Yasuhito Tanaka
    Publication type:
    Article
    31

    Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation.

    Published in:
    Journal of Gastroenterology, 2024, v. 59, n. 7, p. 598, doi. 10.1007/s00535-024-02100-3
    By:
    • Uojima, Haruki;
    • Yamasaki, Kazumi;
    • Sugiyama, Masaya;
    • Kage, Masayoshi;
    • Ishii, Norihiro;
    • Shirabe, Ken;
    • Hidaka, Hisashi;
    • Kusano, Chika;
    • Murakawa, Miyako;
    • Asahina, Yasuhiro;
    • Nishimura, Takashi;
    • Iijima, Hiroko;
    • Sakamoto, Kazumasa;
    • Ito, Kiyoaki;
    • Amano, Keisuke;
    • Kawaguchi, Takumi;
    • Tamaki, Nobuharu;
    • Kurosaki, Masayuki;
    • Suzuki, Takanori;
    • Matsuura, Kentaro
    Publication type:
    Article
    32

    Posttreatment liver function, but not baseline liver function stratifies patient survival after direct-acting antiviral treatment in decompensated cirrhosis with hepatitis C virus.

    Published in:
    Journal of Gastroenterology, 2023, v. 58, n. 12, p. 1211, doi. 10.1007/s00535-023-02039-x
    By:
    • Tahata, Yuki;
    • Hikita, Hayato;
    • Mochida, Satoshi;
    • Enomoto, Nobuyuki;
    • Ido, Akio;
    • Kuroda, Hidekatsu;
    • Miki, Daiki;
    • Kurosaki, Masayuki;
    • Hiasa, Yoichi;
    • Sakamori, Ryotaro;
    • Kawada, Norifumi;
    • Yamashita, Taro;
    • Suda, Goki;
    • Yatsuhashi, Hiroshi;
    • Yoshiji, Hitoshi;
    • Kato, Naoya;
    • Takami, Taro;
    • Nakao, Kazuhiko;
    • Matsuura, Kentaro;
    • Asahina, Yasuhiro
    Publication type:
    Article
    33

    Clinical usefulness of a novel high-sensitivity hepatitis B core-related antigen assay to determine the initiation of treatment for HBV reactivation.

    Published in:
    Journal of Gastroenterology, 2022, v. 57, n. 7, p. 486, doi. 10.1007/s00535-022-01872-w
    By:
    • Suzuki, Takanori;
    • Inoue, Takako;
    • Matsuura, Kentaro;
    • Kusumoto, Shigeru;
    • Hagiwara, Shinya;
    • Ogawa, Shintaro;
    • Yagi, Shintaro;
    • Kaneko, Atsushi;
    • Fujiwara, Kei;
    • Watanabe, Takehisa;
    • Aoyagi, Katsumi;
    • Urata, Yukitomo;
    • Tamori, Akihiro;
    • Kataoka, Hiromi;
    • Tanaka, Yasuhito
    Publication type:
    Article
    34

    TLL1 variant associated with development of hepatocellular carcinoma after eradication of hepatitis C virus by interferon-free therapy.

    Published in:
    2019
    By:
    • Iio, Etsuko;
    • Matsuura, Kentaro;
    • Shimada, Noritomo;
    • Atsukawa, Masanori;
    • Itokawa, Norio;
    • Abe, Hiroshi;
    • Kato, Keizo;
    • Takaguchi, Koichi;
    • Senoh, Tomonori;
    • Eguchi, Yuichiro;
    • Nomura, Hideyuki;
    • Yoshizawa, Kai;
    • Kang, Jong-Hon;
    • Matsui, Takeshi;
    • Hirashima, Noboru;
    • Kusakabe, Atsunori;
    • Miyaki, Tomokatsu;
    • Fujiwara, Kei;
    • Matsunami, Kayoko;
    • Tsutsumi, Susumu
    Publication type:
    journal article
    35

    Combination of PNPLA3 and TLL1 polymorphism can predict advanced fibrosis in Japanese patients with nonalcoholic fatty liver disease.

    Published in:
    2018
    By:
    • Seko, Yuya;
    • Yamaguchi, Kanji;
    • Mizuno, Naoki;
    • Okuda, Keiichiro;
    • Takemura, Masashi;
    • Taketani, Hiroyoshi;
    • Hara, Tasuku;
    • Umemura, Atsushi;
    • Nishikawa, Taichiro;
    • Moriguchi, Michihisa;
    • Yasui, Kohichiroh;
    • Kamaguchi, Mai;
    • Nishioji, Kenichi;
    • Mochizuki, Naomi;
    • Kobayashi, Masao;
    • Mori, Kojiroh;
    • Tanaka, Saiyu;
    • Matsuura, Kentaro;
    • Tanaka, Yasuhito;
    • Itoh, Yoshito
    Publication type:
    journal article
    36
    37
    38
    39
    40

    Bile acid dysmetabolism in the gut‐microbiota‐liver axis under hepatitis C virus infection.

    Published in:
    Liver International, 2022, v. 42, n. 1, p. 124, doi. 10.1111/liv.15041
    By:
    • Inoue, Takako;
    • Funatsu, Yui;
    • Ohnishi, Masaya;
    • Isogawa, Masanori;
    • Kawashima, Keigo;
    • Tanaka, Masaru;
    • Moriya, Kei;
    • Kawaratani, Hideto;
    • Momoda, Rie;
    • Iio, Etsuko;
    • Nakagawa, Hidewaki;
    • Suzuki, Yutaka;
    • Matsuura, Kentaro;
    • Fujiwara, Kei;
    • Nakajima, Atsushi;
    • Yoshiji, Hitoshi;
    • Nakayama, Jiro;
    • Tanaka, Yasuhito
    Publication type:
    Article
    41

    Good arm identification via bandit feedback.

    Published in:
    Machine Learning, 2019, v. 108, n. 5, p. 721, doi. 10.1007/s10994-019-05784-4
    By:
    • Kano, Hideaki;
    • Honda, Junya;
    • Sakamaki, Kentaro;
    • Matsuura, Kentaro;
    • Nakamura, Atsuyoshi;
    • Sugiyama, Masashi
    Publication type:
    Article
    42
    43
    44
    45
    46

    Model incorporating the ITPA genotype identifies patients at high risk of anemia and treatment failure with pegylated-interferon plus ribavirin therapy for chronic hepatitis C.

    Published in:
    Journal of Medical Virology, 2013, v. 85, n. 3, p. 449, doi. 10.1002/jmv.23497
    By:
    • Kurosaki, Masayuki;
    • Tanaka, Yasuhito;
    • Nishida, Nao;
    • Sakamoto, Naoya;
    • Enomoto, Nobuyuki;
    • Matsuura, Kentaro;
    • Asahina, Yasuhiro;
    • Nakagawa, Mina;
    • Watanabe, Mamoru;
    • Sakamoto, Minoru;
    • Maekawa, Shinya;
    • Tokunaga, Katsushi;
    • Mizokami, Masashi;
    • Izumi, Namiki
    Publication type:
    Article
    47
    48

    Genome-wide association study identifies a PSMD3 variant associated with neutropenia in interferon-based therapy for chronic hepatitis C.

    Published in:
    Human Genetics, 2015, v. 134, n. 3, p. 279, doi. 10.1007/s00439-014-1520-7
    By:
    • Iio, Etsuko;
    • Matsuura, Kentaro;
    • Nishida, Nao;
    • Maekawa, Shinya;
    • Enomoto, Nobuyuki;
    • Nakagawa, Mina;
    • Sakamoto, Naoya;
    • Yatsuhashi, Hiroshi;
    • Kurosaki, Masayuki;
    • Izumi, Namiki;
    • Hiasa, Yoichi;
    • Masaki, Naohiko;
    • Ide, Tatsuya;
    • Hino, Keisuke;
    • Tamori, Akihiro;
    • Honda, Masao;
    • Kaneko, Shuichi;
    • Mochida, Satoshi;
    • Nomura, Hideyuki;
    • Nishiguchi, Shuhei
    Publication type:
    Article
    49

    Neutrophil‐to‐lymphocyte ratio at the start of the second course of durvalumab plus tremelimumab therapy predicts therapeutic efficacy in patients with advanced hepatocellular carcinoma: A multicenter analysis.

    Published in:
    Hepatology Research, 2025, v. 55, n. 6, p. 883, doi. 10.1111/hepr.14189
    By:
    • Suzuki, Takanori;
    • Matsuura, Kentaro;
    • Sobue, Satoshi;
    • Kato, Daisuke;
    • Hayashi, Katsumi;
    • Kondo, Hiromu;
    • Anbe, Kaiki;
    • Mizoshita, Tsutomu;
    • Okayama, Kohei;
    • Okumura, Fumihiro;
    • Kimura, Yoshihide;
    • Ozasa, Atsushi;
    • Inada, Hiroki;
    • Tokunaga, Takayuki;
    • Narahara, Satoshi;
    • Kawamura, Hayato;
    • Fujiwara, Kei;
    • Nojiri, Shunsuke;
    • Kataoka, Hiromi;
    • Tanaka, Yasuhito
    Publication type:
    Article
    50

    Factors involved in gastroesophageal varix‐related events in patients with hepatitis C virus‐related compensated and decompensated cirrhosis after direct‐acting antiviral therapy.

    Published in:
    Hepatology Research, 2025, v. 55, n. 3, p. 319, doi. 10.1111/hepr.14131
    By:
    • Tahata, Yuki;
    • Hikita, Hayato;
    • Mochida, Satoshi;
    • Enomoto, Nobuyuki;
    • Kawada, Norifumi;
    • Ido, Akio;
    • Miki, Daiki;
    • Kurosaki, Masayuki;
    • Yoshiji, Hitoshi;
    • Sakamori, Ryotaro;
    • Kuroda, Hidekatsu;
    • Yatsuhashi, Hiroshi;
    • Yamashita, Taro;
    • Hiasa, Yoichi;
    • Kato, Naoya;
    • Miyaaki, Hisamitsu;
    • Ueno, Yoshiyuki;
    • Itoh, Yoshito;
    • Matsuura, Kentaro;
    • Takami, Taro
    Publication type:
    Article